Flagship Harbor Advisors’s BioNTech BNTX Stock Holding History

Flagship Harbor Advisors’s Portfolio BNTX Stock Details BNTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-262	Closed	-$18K	–	686
2020 Q3	$18K	Buy	+262	New	+$18.8K	﹤0.01%	1167

Other funds holding BNTX

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return

Gates Foundation Seattle, Washington $43.5M AUM 14.19% 1-Year Est. Return

Artal Group Luxembourg $931M AUM 41.63% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return

Redmile Group San Francisco, California $1.49B AUM 208.7% 1-Year Est. Return

Temasek Holdings Singapore $37.3B AUM 12.6% 1-Year Est. Return

Flagship Harbor Advisors's BNTX Position: Q4 2020 in Review

Flagship Harbor Advisors sold out of BioNTech (BNTX) in Q4 2020, closing a stake of 262 shares — an estimated $18K sold.

Flagship Harbor Advisors first reported a position in BNTX in Q3 2020 and held it in 1 quarter. The position peaked at $18K in Q3 2020. 195 funds tracked by Wall St. Rank hold BNTX as of Q4 2020.

Flagship Harbor Advisors reported no remaining BioNTech position as of Q4 2020 after selling out during the quarter.
Flagship Harbor Advisors sold 262 BioNTech shares in Q4 2020, an estimated $18K.
Flagship Harbor Advisors first reported a position in BioNTech in Q3 2020 and held it in 1 quarter.
Flagship Harbor Advisors's BioNTech position peaked at $18K in Q3 2020.
195 funds tracked by Wall St. Rank held BioNTech as of Q4 2020.

Based on Flagship Harbor Advisors's 13F filing for Q4 2020, filed 8 Feb 2021.